Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Kryscio

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
JAMA Neurology|June 3, 2014
Secondary prevention trials in Alzheimer disease: the challenge of identifying a meaningful end pointRichard J Kryscio
Neurology|August 2, 2008
Fampridine for MS responders: clinically relevant or hypothesis generating?Richard J Kryscio
Statistical Methods in Medical Research|May 14, 2014
Semi-Markov models for interval censored transient cognitive states with back transitions and a competing riskShaoceng Wei, Richard J Kryscio
Neurology|May 10, 2006
Active control trials for epilepsy: avoiding bias in head-to-head trialsJacqueline A French, Richard J Kryscio
Neurology|May 26, 2021
A New Way to Identify Promising Therapies for Progressive Multiple SclerosisRobert J Fox, Richard J Kryscio
Journal of Biometrics & Biostatistics|November 14, 2013
Are Markov and semi-Markov models flexible enough for cognitive panel data?Richard J Kryscio, Erin L Abner
Neurology|March 2, 2012
Is spinal cord injury a new emerging risk factor for stroke?Elena V Kuklina, Richard J Kryscio
Neurology|November 19, 2011
Does one guideline fit all?Nancy D Richert, Richard J Kryscio
Computational Statistics & Data Analysis|August 12, 2014
Markov Transition Model to Dementia with Death as a Competing EventShaoceng Wei, Liou Xu, Richard J Kryscio
BMC Ophthalmology|May 24, 2017
An objective assessment of the variability in number of drops per bottle of glaucoma medicationDaniel B Moore, Judy Beck, Richard J Kryscio
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
JAMA Neurology|June 3, 2014
Secondary prevention trials in Alzheimer disease: the challenge of identifying a meaningful end pointRichard J Kryscio
Neurology|August 2, 2008
Fampridine for MS responders: clinically relevant or hypothesis generating?Richard J Kryscio
Statistical Methods in Medical Research|May 14, 2014
Semi-Markov models for interval censored transient cognitive states with back transitions and a competing riskShaoceng Wei, Richard J Kryscio
Neurology|May 10, 2006
Active control trials for epilepsy: avoiding bias in head-to-head trialsJacqueline A French, Richard J Kryscio
Neurology|May 26, 2021
A New Way to Identify Promising Therapies for Progressive Multiple SclerosisRobert J Fox, Richard J Kryscio
Journal of Biometrics & Biostatistics|November 14, 2013
Are Markov and semi-Markov models flexible enough for cognitive panel data?Richard J Kryscio, Erin L Abner
Neurology|March 2, 2012
Is spinal cord injury a new emerging risk factor for stroke?Elena V Kuklina, Richard J Kryscio
Neurology|November 19, 2011
Does one guideline fit all?Nancy D Richert, Richard J Kryscio
Computational Statistics & Data Analysis|August 12, 2014
Markov Transition Model to Dementia with Death as a Competing EventShaoceng Wei, Liou Xu, Richard J Kryscio
BMC Ophthalmology|May 24, 2017
An objective assessment of the variability in number of drops per bottle of glaucoma medicationDaniel B Moore, Judy Beck, Richard J Kryscio
Pageof 17